Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

NCT00077402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: fenretinide

Sponsor

Cancer Therapeutics Research Group

Collaborators

[object Object]